Annual Operating Profit
-$78.03 M
-$14.81 M-23.43%
December 31, 2023
Summary
- As of February 7, 2025, ABUS annual operating income is -$78.03 million, with the most recent change of -$14.81 million (-23.43%) on December 31, 2023.
- During the last 3 years, ABUS annual operating profit has fallen by -$20.77 million (-36.26%).
- ABUS annual operating profit is now -334.22% below its all-time high of $33.32 million, reached on December 31, 2012.
Performance
ABUS Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$17.47 M
+$3.90 M+18.25%
September 30, 2024
Summary
- As of February 7, 2025, ABUS quarterly operating income is -$17.47 million, with the most recent change of +$3.90 million (+18.25%) on September 30, 2024.
- Over the past year, ABUS quarterly operating profit has increased by +$1.71 million (+8.92%).
- ABUS quarterly operating profit is now -143.22% below its all-time high of $40.42 million, reached on December 31, 2012.
Performance
ABUS Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$78.55 M
+$3.88 M+4.71%
September 30, 2024
Summary
- As of February 7, 2025, ABUS TTM operating income is -$78.55 million, with the most recent change of +$3.88 million (+4.71%) on September 30, 2024.
- Over the past year, ABUS TTM operating profit has increased by +$1.53 million (+1.91%).
- ABUS TTM operating profit is now -334.90% below its all-time high of $33.44 million, reached on December 31, 2012.
Performance
ABUS TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ABUS Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -23.4% | +8.9% | +1.9% |
| 3 y3 years | -36.3% | +16.6% | -24.2% |
| 5 y5 years | -11.2% | +16.6% | -24.2% |
ABUS Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -23.4% | at low | -62.2% | +18.3% | -25.0% | +4.7% |
| 5 y | 5-year | -36.3% | at low | -62.2% | +18.3% | -44.7% | +4.7% |
| alltime | all time | -334.2% | +22.2% | -143.2% | +55.1% | -334.9% | +21.7% |
Arbutus Biopharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$17.47 M(-18.3%) | -$78.55 M(-4.7%) |
| Jun 2024 | - | -$21.37 M(+11.4%) | -$82.43 M(+2.9%) |
| Mar 2024 | - | -$19.18 M(-6.5%) | -$80.08 M(+2.6%) |
| Dec 2023 | -$78.03 M(+23.4%) | -$20.52 M(-3.9%) | -$78.03 M(-0.6%) |
| Sep 2023 | - | -$21.35 M(+12.3%) | -$78.47 M(+5.0%) |
| Jun 2023 | - | -$19.02 M(+11.0%) | -$74.71 M(+7.4%) |
| Mar 2023 | - | -$17.14 M(-18.2%) | -$69.59 M(+10.1%) |
| Dec 2022 | -$63.22 M(-11.8%) | -$20.95 M(+19.1%) | -$63.22 M(+0.6%) |
| Sep 2022 | - | -$17.60 M(+26.6%) | -$62.87 M(+0.1%) |
| Jun 2022 | - | -$13.90 M(+29.0%) | -$62.83 M(-6.1%) |
| Mar 2022 | - | -$10.77 M(-47.7%) | -$66.88 M(-6.7%) |
| Dec 2021 | -$71.65 M(+25.1%) | -$20.60 M(+17.4%) | -$71.65 M(+6.6%) |
| Sep 2021 | - | -$17.55 M(-2.2%) | -$67.22 M(+3.8%) |
| Jun 2021 | - | -$17.95 M(+15.4%) | -$64.77 M(+8.2%) |
| Mar 2021 | - | -$15.55 M(-3.9%) | -$59.84 M(+4.5%) |
| Dec 2020 | -$57.27 M(-19.7%) | -$16.18 M(+7.1%) | -$57.27 M(+5.5%) |
| Sep 2020 | - | -$15.10 M(+16.0%) | -$54.28 M(-5.8%) |
| Jun 2020 | - | -$13.02 M(+0.3%) | -$57.61 M(-11.9%) |
| Mar 2020 | - | -$12.98 M(-1.6%) | -$65.37 M(-8.4%) |
| Dec 2019 | -$71.34 M(+1.7%) | -$13.18 M(-28.4%) | -$71.34 M(-3.6%) |
| Sep 2019 | - | -$18.43 M(-11.3%) | -$73.98 M(+0.4%) |
| Jun 2019 | - | -$20.78 M(+9.6%) | -$73.66 M(+1.8%) |
| Mar 2019 | - | -$18.95 M(+19.8%) | -$72.34 M(+3.1%) |
| Dec 2018 | -$70.17 M(+0.1%) | -$15.82 M(-12.7%) | -$70.17 M(-4.9%) |
| Sep 2018 | - | -$18.11 M(-7.0%) | -$73.81 M(+7.6%) |
| Jun 2018 | - | -$19.46 M(+16.0%) | -$68.60 M(-0.0%) |
| Mar 2018 | - | -$16.78 M(-13.7%) | -$68.62 M(-2.2%) |
| Dec 2017 | -$70.13 M(-30.1%) | -$19.45 M(+50.8%) | -$70.13 M(-4.1%) |
| Sep 2017 | - | -$12.90 M(-33.8%) | -$73.10 M(-7.7%) |
| Jun 2017 | - | -$19.48 M(+6.5%) | -$79.17 M(-19.7%) |
| Mar 2017 | - | -$18.30 M(-18.4%) | -$98.61 M(-1.7%) |
| Dec 2016 | -$100.29 M(+81.5%) | -$22.42 M(+18.1%) | -$100.29 M(+11.2%) |
| Sep 2016 | - | -$18.98 M(-51.3%) | -$90.21 M(-1.3%) |
| Jun 2016 | - | -$38.92 M(+94.8%) | -$91.39 M(+37.4%) |
| Mar 2016 | - | -$19.98 M(+61.9%) | -$66.52 M(+20.4%) |
| Dec 2015 | -$55.26 M(+67.6%) | -$12.34 M(-38.8%) | -$55.26 M(+3.0%) |
| Sep 2015 | - | -$20.15 M(+43.3%) | -$53.66 M(+33.0%) |
| Jun 2015 | - | -$14.06 M(+61.4%) | -$40.36 M(+13.0%) |
| Mar 2015 | - | -$8.71 M(-18.9%) | -$35.73 M(+8.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | -$32.97 M(+171.3%) | -$10.75 M(+57.0%) | -$32.97 M(+33.7%) |
| Sep 2014 | - | -$6.84 M(-27.4%) | -$24.66 M(+14.9%) |
| Jun 2014 | - | -$9.42 M(+58.2%) | -$21.47 M(+42.0%) |
| Mar 2014 | - | -$5.96 M(+144.6%) | -$15.12 M(+24.4%) |
| Dec 2013 | -$12.15 M(-136.5%) | -$2.44 M(-33.3%) | -$12.15 M(-139.6%) |
| Sep 2013 | - | -$3.65 M(+18.9%) | $30.70 M(-5.7%) |
| Jun 2013 | - | -$3.07 M(+2.6%) | $32.55 M(-1.6%) |
| Mar 2013 | - | -$2.99 M(-107.4%) | $33.08 M(-1.1%) |
| Dec 2012 | $33.32 M(-411.6%) | $40.42 M(-2343.5%) | $33.44 M(-448.4%) |
| Sep 2012 | - | -$1.80 M(-29.0%) | -$9.60 M(+1.9%) |
| Jun 2012 | - | -$2.54 M(-3.9%) | -$9.42 M(-11.3%) |
| Mar 2012 | - | -$2.64 M(+0.9%) | -$10.62 M(-4.7%) |
| Dec 2011 | -$10.69 M(+62.1%) | -$2.62 M(+61.4%) | -$11.14 M(+130.8%) |
| Sep 2011 | - | -$1.62 M(-56.7%) | -$4.83 M(-14.0%) |
| Jun 2011 | - | -$3.74 M(+18.2%) | -$5.62 M(+0.5%) |
| Mar 2011 | - | -$3.17 M(-185.6%) | -$5.59 M(-14.9%) |
| Dec 2010 | -$6.60 M(-18.5%) | $3.70 M(-253.4%) | -$6.57 M(-44.3%) |
| Sep 2010 | - | -$2.41 M(-35.1%) | -$11.79 M(-0.1%) |
| Jun 2010 | - | -$3.71 M(-10.4%) | -$11.80 M(+17.9%) |
| Mar 2010 | - | -$4.14 M(+171.8%) | -$10.01 M(+31.5%) |
| Dec 2009 | -$8.10 M(-3.0%) | -$1.52 M(-37.0%) | -$7.61 M(+26.1%) |
| Sep 2009 | - | -$2.42 M(+26.1%) | -$6.04 M(-3.7%) |
| Jun 2009 | - | -$1.92 M(+10.0%) | -$6.27 M(-33.8%) |
| Mar 2009 | - | -$1.75 M(-3389.6%) | -$9.47 M(+10.6%) |
| Dec 2008 | -$8.34 M(-416.1%) | $53.10 K(-102.0%) | -$8.56 M(+0.4%) |
| Sep 2008 | - | -$2.65 M(-48.3%) | -$8.53 M(+101.7%) |
| Jun 2008 | - | -$5.12 M(+508.8%) | -$4.23 M(-493.1%) |
| Mar 2008 | - | -$841.60 K(-1082.0%) | $1.08 M(-43.9%) |
| Dec 2007 | $2.64 M(-41.4%) | $85.70 K(-94.8%) | $1.92 M(+4.7%) |
| Sep 2007 | - | $1.65 M(+809.3%) | $1.83 M(+909.3%) |
| Jun 2007 | - | $181.50 K | $181.50 K |
| Dec 2006 | $4.50 M(-514.2%) | - | - |
| Dec 2005 | -$1.09 M(-95.3%) | - | - |
| Dec 2004 | -$23.38 M(-32.5%) | - | - |
| Dec 2003 | -$34.65 M(+44.7%) | - | - |
| Dec 2002 | -$23.95 M(+45.2%) | - | - |
| Dec 2001 | -$16.49 M(+53.5%) | - | - |
| Dec 2000 | -$10.74 M(+31.5%) | - | - |
| Dec 1999 | -$8.17 M(-6.6%) | - | - |
| Dec 1998 | -$8.75 M | - | - |
FAQ
- What is Arbutus Biopharma annual operating income?
- What is the all time high annual operating profit for Arbutus Biopharma?
- What is Arbutus Biopharma annual operating profit year-on-year change?
- What is Arbutus Biopharma quarterly operating income?
- What is the all time high quarterly operating profit for Arbutus Biopharma?
- What is Arbutus Biopharma quarterly operating profit year-on-year change?
- What is Arbutus Biopharma TTM operating income?
- What is the all time high TTM operating profit for Arbutus Biopharma?
- What is Arbutus Biopharma TTM operating profit year-on-year change?
What is Arbutus Biopharma annual operating income?
The current annual operating profit of ABUS is -$78.03 M
What is the all time high annual operating profit for Arbutus Biopharma?
Arbutus Biopharma all-time high annual operating income is $33.32 M
What is Arbutus Biopharma annual operating profit year-on-year change?
Over the past year, ABUS annual operating income has changed by -$14.81 M (-23.43%)
What is Arbutus Biopharma quarterly operating income?
The current quarterly operating profit of ABUS is -$17.47 M
What is the all time high quarterly operating profit for Arbutus Biopharma?
Arbutus Biopharma all-time high quarterly operating income is $40.42 M
What is Arbutus Biopharma quarterly operating profit year-on-year change?
Over the past year, ABUS quarterly operating income has changed by +$1.71 M (+8.92%)
What is Arbutus Biopharma TTM operating income?
The current TTM operating profit of ABUS is -$78.55 M
What is the all time high TTM operating profit for Arbutus Biopharma?
Arbutus Biopharma all-time high TTM operating income is $33.44 M
What is Arbutus Biopharma TTM operating profit year-on-year change?
Over the past year, ABUS TTM operating income has changed by +$1.53 M (+1.91%)